Company Overview of InCode BioPharmaceutics, Inc.
InCode BioPharmaceutics, Inc. engages in the pre-clinical development, clinical development, manufacturing including quality control, regulatory and commercialization of biologic products for various applications. It also focuses on therapeutic compounds to treat autoimmune and inflammatory diseases. The company was founded in 2006 and is based in San Diego, California.
5626 Oberlin Drive
San Diego, CA 92121
Founded in 2006
Key Executives for InCode BioPharmaceutics, Inc.
Similar Private Companies By Industry
|Psychiatric Genomics, Inc.||United States|
|Ligandal Technology LLC||United States|
|Cytogam, Inc.||United States|
|Allopartis Biotechnologies, Inc.||United States|
|Wellstat Therapeutics Corporation||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Baltimore, MD | AstraZenecaPosted: Dec 04
- San Francisco, CA | JobvertisePosted: Nov 30
- Princeton, NJ | RGPPosted: Nov 27
- Youngstown, OH | AstraZenecaPosted: Dec 04
Sponsored Financial Commentaries
To contact InCode BioPharmaceutics, Inc., please visit www.incodebp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.